This study is testing a medication approach for people with Major depression, Mental and Behavioural Disorders, or Depressive episode. Participants receive a study treatment and complete follow-up visits and assessments.
In Venezuela
Why is this study shown?
This study is directly about Depression.
Depression, AnxietyOtherOver 18 Years
Countries
Venezuela
Sponsor
Venezuelan Institute of Scientific Investigations (Instituto Venezolano de Investigaciones Científicas) (Venezuela)
This study is testing a medication approach for people with Major depression, Mental and Behavioural Disorders, or Depressive episode. Participants receive a study treatment and complete follow-up visits and assessments.
This study is testing a medication approach for people with Major depression, Mental and Behavioural Disorders, or Depressive episode. Participants receive a study treatment and complete follow-up visits and assessments.
In Canada
Why is this study shown?
This study is directly about Depression.
DepressionOtherOver 18 Years
Countries
Canada
Sponsor
University Hospital of Montreal (CHUM) Research Centre (Canada)
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Austria
Why is this study shown?
This study is directly about Depression.
DepressionDrugA study involving a medication or substance.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Austria
Why is this study shown?
This study is directly about Depression.
DepressionDrug
Countries
Austria, Germany
Sponsor
Clinic for Psychiatry and Psychotherapy of the Ludwig Maximilian University
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This public ISRCTN record appears to relate to depression. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Austria
Why is this study shown?
This study is directly about Depression.
DepressionDrug
Countries
Austria
Sponsor
Siegfried KASPER, O.Univ.Prof.Dr.Dr.h.c., Medizinische Universität Wien
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.